Previous close | 25.50 |
Open | 25.50 |
Bid | 24.30 |
Ask | 24.90 |
Strike | 55.00 |
Expiry date | 2026-01-16 |
Day's range | 25.50 - 25.50 |
Contract range | N/A |
Volume | |
Open interest | 44 |
AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that, following clearance from the French Ministry of Economy and satisfaction of all other closing conditions, AstraZeneca (LSE/STO/Nasda
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx Corporation (FDX).